[ACRX] QoQ Quarter Result on 31-Mar-2014 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-May-2014
Financial Year
2014
Quarter
31-Mar-2014 [#Q1]
Profit Trend
QoQ- -154.20%
YoY- 24.53%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
Revenue 226 4,825 71 95 27,607 548 407 -32.36%
PBT -13,818 671 -10,575 -9,631 17,769 -10,986 -17,447 -14.36%
Tax -1,218 6,556 2,215 -618 -1,742 -1,980 -9,273 -74.06%
NP -13,818 671 -10,575 -9,631 17,769 -10,986 -17,447 -14.36%
Tax Rate - -977.05% - - 9.80% - - -
Total Cost 14,044 4,154 10,646 9,726 9,838 11,534 17,854 -14.75%
Ratio Analysis
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
NP Margin -6,114.16 13.91 -14,894.37 -10,137.89 64.36 -2,004.74 -4,286.73 26.62%
Per Share
31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 CAGR
EPS -6.30 0.40 -4.88 -4.46 8.20 -5.30 -9.36 -23.14%
EPS Diluted -6.22 -2.60 -4.77 -4.46 8.20 -5.30 -9.36 -23.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.